SPS PGD template for the supply of emtricitabine/tenofovir disoproxil and raltegravir tablets for HIV Post Exposure Prophylaxis (HIV PEP).

Provenance

Created by SPS, the British Association of Sexual Health and HIV (BASHH), the British Association of HIV (BHIVA) and the support of specialist stakeholders working within clinical practice for sexual health services.

Version 2 template

Version 2.0 of the PEP PGD template has been published – this is valid for use from August 2024 and has been published in April 2024 to allow organisations time to undertake the required authorisation process.

Version 1.1 will be withdrawn when it reaches it’s expiry date.

PGD template attachment

The template PGD is attached below to download and use in conjunction with our implementation advice.

More sexual health PGD templates

All PGD templates

Templates

National PGD templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.

Update history

  1. New template V2.0 published and explanatory text added
  1. Title, URL and summary amended.
  1. Updated PGD template added
  1. Published

Print this page